[Federal Register Volume 62, Number 150 (Tuesday, August 5, 1997)]
[Notices]
[Pages 42137-42138]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 97-20555]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Substance Abuse and Mental Health Services Administration
Center for Substance Abuse Prevention; Notice of Meeting
Pursuant to Pub. L. 92-463, notice is hereby given of the meeting
of the Drug Testing Advisory Board of the SAMHSA Center for Substance
Abuse Prevention in September 1997.
The two-day scientific meeting will be to continue discussing
alternative specimens and technologies of drug testing (i.e., hair,
saliva, sweat, and non-instrument based-on-site tests) as they apply to
workplace drug testing programs. The entire meeting is open to the
public; however, attendance by the public will be limited to space
available. Therefore, it would be helpful if those planning to attend
would pre-register by following Registration instructions below. There
will be a limited time for public comment during the meeting. If anyone
needs special accommodations for persons with disabilities please
notify the Contact listed below. Any individual desiring to make a
formal comment should notify the Contact person listed below before
August 29.
The purpose of the meeting is: (1) To review the proposed
principles and criteria associated with a forensic workplace drug
testing program that were presented at the April 28-30, 1997, DTAB
meeting and determine if those are the appropriate standards that any
drug testing program needs to satisfy; (2) to review the information
and scientific studies presented or submitted by the representatives of
the alternative specimens and technology industries during and/or after
the April 28-30 DTAB meeting, to determine their strengths and
weaknesses, what criteria they satisfy, and what areas may need
improvement; and (3) to make recommendations to assist these
alternative specimens and technologies to satisfy the criteria.
An agenda for this meeting and a roster of board members may be
obtained from: Ms. Giselle Hersh, Division of Workplace Programs, Room
13A-54, 5600 Fishers Lane, Rockville, MD 20857, Telephone (301) 443-
6014.
Substantive program information may be obtained from the contact
whose name and telephone number is listed below.
Committee Name: Drug Testing Advisory Board.
Meeting Date: September 9-10, 1997.
Place: Sheraton National Hotel, Columbia Pike & Washington Blvd,
Arlington, Virginia 22204, Phone: (800) 468-9090.
Open: September 9, 1997, 8:30 a.m.-5:00 p.m., September 10,
1997, 8:30 a.m.-4:00 p.m.
Registration: Pre-register by calling: (301) 443-6014 or by FAX:
(301) 443-3031 for individuals planning to attend: full name,
organization and telephone number or sign in upon arrival; there is
no registration fee.
Contact: Donna M. Bush, Ph.D., Executive Secretary, Telephone:
(301) 443-6014 and FAX: (301) 443-3031.
[[Page 42138]]
Dated: July 30, 1997.
Jeri Lipov,
Committee Management Officer, Substance Abuse and Mental Health
Services Administration.
[FR Doc. 97-20555 Filed 8-4-97; 8:45 am]
BILLING CODE 4162-20-M
